Summary
Axon Enterprise, Inc. reported strong revenue growth in the first quarter of 2023, with total net sales increasing by 33.8% year-over-year to $343.0 million. This growth was driven by robust performance in both the Software and Sensors segment (+46.9%) and the TASER segment (+17.4%). The Software and Sensors segment, in particular, saw significant boosts from Axon Evidence and Cloud Services, as well as Axon Fleet Systems. Despite the impressive revenue increase, net income decreased to $45.1 million from $54.9 million in the prior year, primarily due to a notable increase in operating expenses, particularly in sales, general, and administrative (SG&A) and research and development (R&D), which rose by 29.3% and 46.5% respectively. This increase in expenses was largely attributed to higher headcount, increased stock-based compensation, and higher salaries and benefits. The company ended the quarter with a healthy cash and cash equivalents balance of $263.4 million, though this was a decrease from the prior quarter. Axon also highlighted its substantial remaining performance obligations of approximately $4.8 billion, providing visibility into future contracted revenues. While the company faces ongoing risks related to supply chain, litigation, and macroeconomic conditions, its strategic investments in cloud-based solutions and continued expansion in the public safety technology market position it for sustained growth.
Financial Highlights
51 data points| Revenue | $344.34M |
| Cost of Revenue | $139.88M |
| Gross Profit | $204.46M |
| R&D Expenses | $70.93M |
| SG&A Expenses | $115.95M |
| Operating Expenses | $186.87M |
| Operating Income | $17.59M |
| Net Income | $45.90M |
| EPS (Basic) | $0.63 |
| EPS (Diluted) | $0.62 |
| Shares Outstanding (Basic) | 72.64M |
| Shares Outstanding (Diluted) | 73.88M |
Key Highlights
- 1Total net sales increased by 33.8% to $343.0 million in Q1 2023 compared to Q1 2022.
- 2The Software and Sensors segment revenue grew by 46.9%, driven by Axon Evidence and Cloud Services and Axon Fleet Systems.
- 3TASER segment revenue increased by 17.4%, with significant contributions from cartridges and TASER devices.
- 4Operating expenses increased substantially, with SG&A up 29.3% and R&D up 46.5%, impacting profitability.
- 5Net income decreased to $45.1 million from $54.9 million year-over-year, impacted by higher operating expenses and a lower unrealized gain on investments compared to the prior year.
- 6Remaining performance obligations stand at approximately $4.8 billion, indicating strong future contracted revenue.
- 7The company maintained a strong liquidity position with $263.4 million in cash and cash equivalents at the end of the quarter.